The quality of water for pharmaceutical production (purified water, water for injection, and ultrapure water) is quantified and regulated through four parameters – total organic carbon (TOC), ...

The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...

As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The bioburden testing market is witnessing growth due to factors such as growth in the medical devices, ...

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to ...

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...

DUBLIN--(BUSINESS WIRE)--The "Bioburden Testing Market by Product, Test, Application, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. The bioburden ...

WILMINGTON, Mass.—October 20, 2014 – Charles River Laboratories International, Inc. (NYSE: CRL) today introduced the PTS-Micro™ system, a new technology platform designed for rapid microbial burden ...

Swiss CDMO Lonza is making a move to strengthen and speed up quality control testing with the purchase of French rapid microbiology testing firm Redberry SAS. The acquisition, announced Monday, Oct.

Lonza, announced that it has signed an agreement to acquire Redberry SAS (Redberry), a company specializing in rapid microbiology testing solutions using solid-phase cytometry (SPC) technology. The ...